---
title: "12 Health Care Stocks Moving In Thursday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297216897.md"
description: "On Thursday, several healthcare stocks experienced significant intraday volatility. Gainers included Celularity (up 134%), Propanc Biopharma (up 121%), and VolitionRX (up 57%). Conversely, losers saw declines in BeyondSpring (-15%), Aprea Therapeutics (-15%), and Apimeds Pharmaceuticals (-13%). Notable earnings reports were released for Hyperliquid Strategies and HealthEquity."
datetime: "2026-08-27T17:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297216897.md)
  - [en](https://longbridge.com/en/news/297216897.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297216897.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Thursday's Intraday Session

### Gainers

-   **Celularity** (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regular session. The company's market cap stands at $25.0 million.
-   **Propanc Biopharma** (NASDAQ:PPCB) stock increased by 121.44% to $2.37. The company's market cap stands at $2.4 million.
-   **VolitionRX** (AMEX:VNRX) shares rose 57.13% to $0.53. The company's market cap stands at $4.8 million.
-   **Cypherpunk Technologies** (NASDAQ:CYPH) stock rose 21.16% to $1.98. The company's market cap stands at $175.6 million.
-   **Hyperliquid Strategies** (NASDAQ:PURR) stock moved upwards by 20.54% to $13.94. The market value of their outstanding shares is at $2.3 billion. The company's, Q4 earnings came out today.
-   **AEON Biopharma** (AMEX:AEON) shares moved upwards by 20.03% to $0.3. The market value of their outstanding shares is at $12.5 million.

### Losers

-   **BeyondSpring** (NASDAQ:BYSI) shares declined by 15.0% to $0.59 during Thursday's regular session. The company's market cap stands at $28.3 million.
-   **Aprea Therapeutics** (NASDAQ:APRE) shares fell 14.99% to $0.83. The market value of their outstanding shares is at $12.3 million.
-   **Apimeds Pharmaceuticals** (AMEX:APUS) stock fell 13.05% to $4.0. The market value of their outstanding shares is at $6.9 million.
-   **Basel Medical Group** (NASDAQ:BMGL) stock fell 12.56% to $5.19. The company's market cap stands at $9.2 million.
-   **Clinuvel Pharmaceuticals** (NASDAQ:CUVL) stock declined by 11.31% to $6.78. The market value of their outstanding shares is at $385.4 million.
-   **HealthEquity** (NASDAQ:HQY) stock fell 11.07% to $92.86. The market value of their outstanding shares is at $8.7 billion. As per the news, the Q2 earnings report came out today. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [APUS.US](https://longbridge.com/en/quote/APUS.US.md)
- [PPCB.US](https://longbridge.com/en/quote/PPCB.US.md)
- [CELU.US](https://longbridge.com/en/quote/CELU.US.md)
- [HQY.US](https://longbridge.com/en/quote/HQY.US.md)
- [BYSI.US](https://longbridge.com/en/quote/BYSI.US.md)
- [CELUW.US](https://longbridge.com/en/quote/CELUW.US.md)
- [APRE.US](https://longbridge.com/en/quote/APRE.US.md)
- [VNRX.US](https://longbridge.com/en/quote/VNRX.US.md)
- [PURR.US](https://longbridge.com/en/quote/PURR.US.md)
- [CYPH.US](https://longbridge.com/en/quote/CYPH.US.md)
- [AEON.US](https://longbridge.com/en/quote/AEON.US.md)
- [BMGL.US](https://longbridge.com/en/quote/BMGL.US.md)
- [CUVL.US](https://longbridge.com/en/quote/CUVL.US.md)
- [PPCBD.US](https://longbridge.com/en/quote/PPCBD.US.md)

## Related News & Research

- [HealthEquity (NASDAQ:HQY) Issues FY 2027 Earnings Guidance](https://longbridge.com/en/news/297190021.md)
- [HealthEquity director Adrian T. Dillon disposes of $798,685 in common shares](https://longbridge.com/en/news/297234074.md)
- [Why Is Hyperliquid Strategies Stock Up on Friday?](https://longbridge.com/en/news/297355881.md)
- [BeyondSpring highlights confirmatory Phase 3 DUBLIN-4 trial plan for plinabulin in post-ICI NSCLC](https://longbridge.com/en/news/297642398.md)
- [HealthEquity Q2 revenue beats on HSA account growth](https://longbridge.com/en/news/297183740.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**